Canadian Journal of Anaesthesia

, Volume 50, Issue 7, pp 753–753 | Cite as

Landiolol for the treatment of tachyarrhythmia associated with atrial fibrillation

  • Junichi Ogata
  • Takashi Okamoto
  • Kouichiro Minami
Correspondence

Keywords

Amiodarone Landiolol Difficult Intubation Monohydrochloride Carbonylamino 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. 1.
    Atarashi H, Kuruma A, Yashima M, et al. Pharmacokinetics of landiolol hydrochloride, a new ultra-short-acting beta-blocker, in patients with cardiac arrhythmias. Clin Pharmacol Ther 2000; 68: 143–50.PubMedCrossRefGoogle Scholar
  2. 2.
    Muraki K, Nakagawa H, Nagano N, et al. Effects of ONO-1101, a novel beta-antagonist, on action poten- tial and membrane currents in cardiac muscle. J Pharmacol Exp Ther 1996; 278: 555–63.PubMedGoogle Scholar
  3. 3.
    Iguchi S, Iwamura H, Nishizaki M, et al. Development of a highly cardioselective ultra short-acting beta- blocker, ONO-1101. Chem Pharm Bull (Tokyo) 1992; 40: 1462–9.Google Scholar

Copyright information

© Canadian Anesthesiologists 2003

Authors and Affiliations

  • Junichi Ogata
    • 1
  • Takashi Okamoto
    • 1
  • Kouichiro Minami
    • 1
  1. 1.FukuokaJapan

Personalised recommendations